Department of Psychiatry, University Hospital Centre Osijek, J. Huttlera 4, 31000 Osijek, Croatia,
Psychiatr Danub. 2014 Jun;26(2):100-7.
It is well-known that placebo is a substance without medical effects, which benefits the health status because of the patient's belief that the substance is effective and that the nocebo is defined as a substance without medical effects but which worsenes the health status of the person taking it by the negative beliefs and expectations of the patient. Starting with the history of the placebo effect and giving a review of the most significant studies reporting about the placebo effect from 1939-2013 it was our intention to give the all-around look on this phenomena discussing the neurobiological and other theories of its origin and concentrating especially on the field of psychiatry and finally coming to conclusions regarding the conductance of clinical trials and ethics. Regarding psychiatry, the placebo effect has a substantial role in most of psychiatric conditions including depression, anxiety, addictions, and contrary to what may have been expected, schizophrenia. Likewise, the nocebo effect is not to be neglected as the studies are being conducted to identify the factors causing it so it could be prevented.
众所周知,安慰剂是一种没有医疗效果的物质,但由于患者相信该物质有效,因此对健康状况有益,而 则被定义为一种没有医疗效果的物质,但由于患者的负面信念和期望,会使服用它的人的健康状况恶化。从安慰剂效应的历史开始,我们回顾了 1939 年至 2013 年期间关于安慰剂效应的最重要研究报告,旨在全面探讨这一现象,讨论其起源的神经生物学和其他理论,并特别关注精神病学领域,最后就临床试验和伦理学的实施得出结论。就精神病学而言,安慰剂效应在包括抑郁症、焦虑症、成瘾等在内的大多数精神疾病中都起着重要作用,与人们可能预期的相反,精神分裂症也是如此。同样,不能忽视 效应,因为正在进行研究以确定导致它的因素,以便可以预防它。